MOA Biotech ApS: Financial statements 2024
CVR: 38844679
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MOA Biotech ApS (CVR 38844679) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -8,928 and a net result of DKK -8,899 compared with DKK -3,370 the year before. Equity in the 2024 report amounted to DKK 10,418. The solvency ratio was 67.6%.
- Gross Profit
- DKK -8,928
- Profit/Loss
- DKK -8,899
- Equity
- DKK 10,418
- Total Assets
- DKK 15,417
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9 t. | -9 t. | 10 t. | - |
| 2023 | - | -9 t. | -3 t. | 19 t. | - |
| 2022 | - | -7 t. | -17 t. | 23 t. | - |
| 2021 | - | -8 t. | -8 t. | 40 t. | - |
| 2020 | - | -8 t. | -8 t. | 48 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MOA Biotech ApS has published its annual report for 2023. Gross profit came to DKK -9,250, and the net result was DKK -3,370.
About MOA Biotech ApS
MOA Biotech ApS is a Danish company of the type Anpartsselskab based in Odense S, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Østergaard Andersen. The company is owned by Morten Østergaard Andersen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,297 and a net result of DKK -9,297 compared with DKK -8,899 the year before. Equity in the 2025 report amounted to DKK 1,121.